[go: up one dir, main page]

DE60131927D1 - Heterosubstituierte taxan-c10-acetate als antitumormittel - Google Patents

Heterosubstituierte taxan-c10-acetate als antitumormittel

Info

Publication number
DE60131927D1
DE60131927D1 DE60131927T DE60131927T DE60131927D1 DE 60131927 D1 DE60131927 D1 DE 60131927D1 DE 60131927 T DE60131927 T DE 60131927T DE 60131927 T DE60131927 T DE 60131927T DE 60131927 D1 DE60131927 D1 DE 60131927D1
Authority
DE
Germany
Prior art keywords
heterosubstituted
antitumoring
taxan
acetates
substituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60131927T
Other languages
English (en)
Inventor
Robert A Holton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florida State University Research Foundation Inc
Original Assignee
Florida State University Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florida State University Research Foundation Inc filed Critical Florida State University Research Foundation Inc
Application granted granted Critical
Publication of DE60131927D1 publication Critical patent/DE60131927D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE60131927T 2000-02-02 2001-02-02 Heterosubstituierte taxan-c10-acetate als antitumormittel Expired - Lifetime DE60131927D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17966900P 2000-02-02 2000-02-02
PCT/US2001/003553 WO2001056564A1 (en) 2000-02-02 2001-02-02 C10 heterosubstituted acetate taxanes as antitumor agents

Publications (1)

Publication Number Publication Date
DE60131927D1 true DE60131927D1 (de) 2008-01-31

Family

ID=22657495

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60131927T Expired - Lifetime DE60131927D1 (de) 2000-02-02 2001-02-02 Heterosubstituierte taxan-c10-acetate als antitumormittel

Country Status (21)

Country Link
US (4) US6664275B2 (de)
EP (1) EP1165068B1 (de)
JP (1) JP2003521514A (de)
KR (1) KR20020002488A (de)
CN (1) CN1362876A (de)
AT (1) ATE381328T1 (de)
AU (1) AU776767B2 (de)
BR (1) BR0104350A (de)
CA (1) CA2368502A1 (de)
CZ (1) CZ20013523A3 (de)
DE (1) DE60131927D1 (de)
HK (1) HK1047896A1 (de)
HU (1) HUP0200750A3 (de)
IL (1) IL145639A (de)
MX (1) MXPA01009924A (de)
NO (1) NO20014756L (de)
NZ (1) NZ514406A (de)
PL (1) PL350027A1 (de)
TW (1) TWI257390B (de)
WO (1) WO2001056564A1 (de)
ZA (1) ZA200108052B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638973B2 (en) * 2000-02-02 2003-10-28 Fsu Research Foundation, Inc. Taxane formulations
IL145639A (en) * 2000-02-02 2007-02-11 Univ Florida State Res Found Cetro-converted Texanate acetate in C10 as anti-cancer agents
BR0313197A (pt) 2002-08-02 2005-08-09 Immunogen Inc Agentes citotóxicos contendo potentes taxanos e seu uso terapêutico
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
SI1664033T1 (sl) * 2003-09-25 2008-04-30 Tapestry Pharmaceuticals Inc Analogi 9,10-alfa,alfa-oh-taksana in postopki za proizvodnjo le-teh
AU2004275881A1 (en) 2003-09-25 2005-04-07 Tapestry Pharmaceuticals, Inc. 9,10-alpha,alpha-OH-taxane analogs and methods for production thereof
CN1712399B (zh) * 2004-06-24 2010-08-11 中国医学科学院药物研究所 紫杉醇和免疫增强剂胞壁酰二肽共轭物的制备及用途
KR100627436B1 (ko) * 2005-10-18 2006-09-22 주식회사 시드컴 차량용 요일체킹장치
US11786504B2 (en) 2006-09-28 2023-10-17 Tapestry Pharmaceuticals, Inc. Taxane analogs for the treatment of brain cancer
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
US11873308B2 (en) 2006-11-06 2024-01-16 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008109360A1 (en) 2007-02-28 2008-09-12 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
CN101715342A (zh) * 2007-03-19 2010-05-26 因弗拉布洛克制药公司 钴胺素紫杉烷生物结合物
KR20100133475A (ko) * 2008-04-10 2010-12-21 아브락시스 바이오사이언스, 엘엘씨 소수성 탁산 유도체의 조성물 그의 용도
AU2009234127B2 (en) * 2008-04-10 2015-04-30 Abraxis Bioscience, Llc Compositions of hydrophobic taxane derivatives and uses thereof
KR101851117B1 (ko) 2010-01-29 2018-04-23 마이크로닉스 인코포레이티드. 샘플-투-앤서 마이크로유체 카트리지
CN102964425B (zh) 2010-05-27 2016-02-24 深圳信立泰药业股份有限公司 多西紫杉醇与胞壁酰二肽简化物的共缀物及抗肿瘤作用
US20150346097A1 (en) 2012-12-21 2015-12-03 Micronics, Inc. Portable fluorescence detection system and microassay cartridge
KR102102123B1 (ko) 2012-12-21 2020-04-20 퍼킨엘머 헬스 사이언시즈, 아이엔씨. 유체 공학 회로 및 관련 제조 방법
WO2014100743A2 (en) 2012-12-21 2014-06-26 Micronics, Inc. Low elasticity films for microfluidic use
EP2994543B1 (de) 2013-05-07 2018-08-15 Micronics, Inc. Vorrichtung zur herstellung und analyse von nukleinsäuren
AU2014262710B2 (en) 2013-05-07 2019-09-12 Revvity Health Sciences, Inc. Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions
EP2994750B1 (de) 2013-05-07 2020-08-12 PerkinElmer Health Sciences, Inc. Mikrofluidische vorrichtungen und verfahren zur durchführung von serumtrennung und blutkreuzproben
CA3036572A1 (en) 2016-09-19 2018-03-22 Genmark Diagnostics, Inc. Instrument for processing cartridge for performing assays in a closed sample preparation and reaction system

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960790A (en) 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5243045A (en) 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5430160A (en) 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
US5721268A (en) 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5714513A (en) 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
SG46582A1 (en) 1991-09-23 1998-02-20 Univ Florida State 10-Desacetoxytaxol derivatives
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5227400A (en) 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
CA2087359A1 (en) 1992-01-15 1993-07-16 Ramesh N. Patel Enzymatic processes for resolution of enantiomeric mixtures of compoundsuseful as intermediates in the preparation of taxanes
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5939561A (en) 1992-03-10 1999-08-17 Rhone-Poulence Rorer S.A. Process for the preparation of β-phenylisoserine and β-lactam and their analogues
US5200534A (en) 1992-03-13 1993-04-06 University Of Florida Process for the preparation of taxol and 10-deacetyltaxol
FR2702212B1 (fr) 1993-03-02 1995-04-07 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5703247A (en) 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
EP0703909B1 (de) 1993-06-11 2000-04-26 PHARMACIA & UPJOHN COMPANY Delta 6, 7-taxolen, antineoplastische verwendung und diese enthaltende pharmazeutische zusammenstellungen
IL109926A (en) 1993-06-15 2000-02-29 Bristol Myers Squibb Co Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
TW397866B (en) 1993-07-14 2000-07-11 Bristol Myers Squibb Co Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
FR2711369B1 (fr) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
AU4133096A (en) 1994-10-28 1996-05-23 Research Foundation Of The State University Of New York, The Taxoid derivatives, their preparation and their use as antitumor agents
MA23823A1 (fr) 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5780653A (en) 1995-06-07 1998-07-14 Vivorx Pharmaceuticals, Inc. Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
CA2231837A1 (en) 1995-09-13 1997-03-20 Florida State University Radiosensitizing taxanes and their pharmaceutical preparations
TW338042B (en) * 1995-10-31 1998-08-11 Clary Kk Process for producing all trans-form polyprenols
US5756536A (en) * 1995-11-03 1998-05-26 Purdue Research Foundation Microbial transformation of taxol and cephalomannine
US5899043A (en) * 1995-12-18 1999-05-04 Engineering Certifiers Ltd. Ductile-failure anchors for concrete elements
US5767297A (en) 1997-02-05 1998-06-16 Ensuiko Sugar Refining Co., Ltd. Taxoid derivative and method of producing thereof
CN1221412A (zh) 1996-05-06 1999-06-30 佛罗里达州立大学 1-脱氧浆果赤霉素ⅲ,1-脱氧紫杉醇和1-脱氧紫杉醇类似物及其制备方法
CN1097044C (zh) * 1996-07-15 2002-12-25 亚库尔特株式会社总社 紫杉烷衍生物以及含有该衍生物的药物
US5811452A (en) 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
HU224589B1 (hu) * 1997-06-03 2005-11-28 Ensuiko Sugar Refining Co., Ltd. Taxoidszármazékok és eljárás előállításukra
SE9702776D0 (sv) * 1997-07-22 1997-07-22 Pharmacia & Upjohn Ab Method of preparing pharmaceutical compositions
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
KR20010111580A (ko) 2000-02-02 2001-12-19 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 개선된 용해도를 갖는 탁산 제형물
IL145639A (en) * 2000-02-02 2007-02-11 Univ Florida State Res Found Cetro-converted Texanate acetate in C10 as anti-cancer agents

Also Published As

Publication number Publication date
CN1362876A (zh) 2002-08-07
HUP0200750A2 (hu) 2002-07-29
EP1165068B1 (de) 2007-12-19
US6872837B2 (en) 2005-03-29
AU3479201A (en) 2001-08-14
US20020068755A1 (en) 2002-06-06
KR20020002488A (ko) 2002-01-09
AU776767B2 (en) 2004-09-23
HK1047896A1 (zh) 2003-03-14
MXPA01009924A (es) 2003-08-01
JP2003521514A (ja) 2003-07-15
US20040024051A1 (en) 2004-02-05
IL145639A (en) 2007-02-11
WO2001056564A1 (en) 2001-08-09
TWI257390B (en) 2006-07-01
US20070249707A1 (en) 2007-10-25
NO20014756L (no) 2001-11-29
US7157474B2 (en) 2007-01-02
US6664275B2 (en) 2003-12-16
BR0104350A (pt) 2002-01-02
CA2368502A1 (en) 2001-08-09
HUP0200750A3 (en) 2005-02-28
ZA200108052B (en) 2003-12-01
US20050143447A1 (en) 2005-06-30
EP1165068A1 (de) 2002-01-02
NO20014756D0 (no) 2001-10-01
IL145639A0 (en) 2002-06-30
NZ514406A (en) 2005-01-28
ATE381328T1 (de) 2008-01-15
CZ20013523A3 (cs) 2002-03-13
PL350027A1 (en) 2002-10-21

Similar Documents

Publication Publication Date Title
DE60131927D1 (de) Heterosubstituierte taxan-c10-acetate als antitumormittel
MY137637A (en) C7 ester substituted taxanes
DOP2001000151A (es) Derivados de imidazopirimidina y derivados de triazolopimidina.
NO20034660D0 (no) Spiropyrazolforbindelser
DE60136430D1 (de) Heterosubstituierte c7-taxanacetate als antitumormittel
TR200102855T1 (tr) Antitümör ajanları olarak C10 karbonat ikameli taksanlar.
ATE432928T1 (de) C10-taxanester als antitumormittel
DE60134814D1 (de) C10-carbamoyloxysubstituierte taxane als antitumormittel
DE60133600D1 (de) C7-carbamoyloxysubstituierte taxane als antitumormittel
EP1221445A4 (de) Pentacyclische taxan-verbindungen
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
MXPA01007972A (es) Esteres de taxanos c10 sustituidos.
SG125888A1 (en) C10 carbonate substituted taxanes
ATE282611T1 (de) Stolonoxide
SG125889A1 (en) C7 ester subsituted taxanes

Legal Events

Date Code Title Description
8332 No legal effect for de